CoChat

Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4

Open access

The DOI matches its Crossref record; 92 of the 95 references it cites were found in a registry or an index; 35 of the 48 sources its claims cite were checked for support.

Abstract

Abstract Melanoma cells rely on developmental programs during tumor initiation and progression. Here we show that the embryonic stem cell (ESC) factor Sall4 is re-expressed in the Tyr::Nras Q61K ; Cdkn2a −/− melanoma model and that its expression is necessary for primary melanoma formation. Surprisingly, while Sall4 loss prevents tumor formation, it promotes micrometastases to distant organs in this melanoma-prone mouse model. Transcriptional profiling and in vitro assays using human melanoma cells demonstrate that SALL4 loss induces a phenotype switch and the acquisition of an invasive phenotype. We show that SALL4 negatively regulates invasiveness through interaction with the histone deacetylase (HDAC) 2 and direct co-binding to a set of invasiveness genes. Consequently, SALL4 knock down, as well as HDAC inhibition, promote the expression of an invasive signature, while inhibition of histone acetylation partially reverts the invasiveness program induced by SALL4 loss. Thus, SALL4 appears to regulate phenotype switching in melanoma through an HDAC2-mediated mechanism.

Overview

CoChat Summary

## TL;DR

SALL4 is re-expressed in melanoma-prone melanocytes and is needed for primary melanoma growth, but its loss shifts cells toward an invasive, micrometastatic state. The paper links this switch to SALL4’s repression of invasiveness genes through HDAC2-dependent epigenetic control.

## Key findings

  • In Tyr::NrasQ61K; Cdkn2a−/− mice, Sall4 was among the top 20 upregulated genes in hyperplastic versus wild-type melanocytes, with logFC 9.59 and p < 0.0001; SALL4 protein was also detected in human melanoma tissue but not healthy human melanocytes.
  • Conditional Sall4 ablation impaired primary melanoma formation, while Sall4−/− cko and Sall4+/− cko mice had significantly more lung micrometastases than controls.
  • In human melanoma cells, SALL4 knockdown decreased proliferation and increased invasion; RNA-seq found 1004 genes upregulated and 1140 genes downregulated after siSALL4 treatment.
  • SALL4 and HDAC2 co-occupied direct target loci, including invasiveness-associated genes; the paper reports 184 direct SALL4-HDAC2 targets that increased expression after SALL4 knockdown, enriched for cell adhesion, TGFβ signaling, angiogenesis, and EMT.
  • H3K27ac ChIP-seq after SALL4 knockdown showed more gained than lost acetylation peaks; within TSS-proximal changes, there were 2566 genes with gained H3K27ac and 1131 with lost H3K27ac, and 261 of the gained-H3K27ac genes also had increased mRNA while 137 of the lost-H3K27ac genes had decreased mRNA.

## Methods

  • In vivo mouse model: Tyr::NrasQ61K; Cdkn2a−/− melanoma-prone mice were crossed with Tyr::CreERT2, Sall4lox/lox, and R26R-LSL-GFP lines; tamoxifen was used for conditional Sall4 deletion and melanoma growth/metastasis were quantified.
  • Human cell work: Multiple human melanoma cell lines (including M010817, M070302, M150548, WM1361A, MM150536, M121224) were used for siRNA knockdown, proliferation, migration, invasion assays, xenografts, qRT-PCR, RNA-seq, Co-IP, CUT&RUN, and H3K27ac ChIP-seq.
  • Analysis: Differential expression was analyzed with edgeR for mouse RNA-seq and DESeq2 for human RNA-seq; enrichment used MetaCore and GSEA; CUT&RUN peaks were called with SEACR, and H3K27ac ChIP-seq peaks with HOMER.

## Limitations

  • The paper states that the exact genomic loci regulated by the SALL4/HDAC2 complex are difficult to define because some acetylation changes may occur at distant regulatory elements rather than at the same bound site.
  • It notes that for some previously known SALL4 targets (for example PTEN and SALL1), binding was detected but no differential acetylation or transcriptional changes were observed here, suggesting SALL4 regulates a specific subset of targets in melanoma.
  • Evident from the text: several conclusions rely on cell lines and mouse models, so direct patient-level clinical impact is not established in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-021-25326-8

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Sall4 is upregulated in hyperplastic melanocytes. a Experimental scheme of isolated melanocytes for RNA sequencing either from Tyr::CreERT2; R26R-LSL-tdTomato wild-type mice or Tyr::CreERT2; R26R-LSL-tdTomato; Tyr::NrasQ61K; Cdkn2a−/− mice with hyperplastic, melanoma-prone skin. At the age of 4 months, the mice were injected on 5 consecutive days with 80 µg g−1 body weight tamoxifen to induce tdTomato expression in melanocytes. The hair growth cycle in wild-type animals was synchronized by dorsal hair plucking. Melanocytes were isolated from mouse back skin of wild-type and melanoma model mice (3–6 mice per sample) and FACS sorted for cKit (staining) and tdTomato (endogenous). b Row z-score heatmap of normalized counts from RNA sequencing as illustrated in a. Visualized are the top 20 most upregulated genes comparing hyperplastic (Tyr::NrasQ61K; Cdkn2a−/−) to wild-type melanocytes. Genes are ordered top to bottom with genes with highest LogFC values on top. Cutoffs were set at p values < 0.05 and FDR < 0.05. Sall4 (LogFC value = 9.59) represents the only and hence highest upregulated transcription factor within those top 20 upregulated genes. The complete list of all differentially expressed genes can be found under Supplementary Data 1. c Immunohistochemical staining of wild-type melanocytes in murine hair follicles (left panel) and melanoma-prone melanocytes in hyperplastic Tyr::NrasQ61K; Cdkn2a−/− mouse skin (right panel). Arrowheads point towards wild-type melanocytes with undetectable Sall4 expression; arrows point towards hyperplastic and rare wild-type melanocytes with detectable Sall4 protein. Experiment has been repeated independently three times with similar results. Scale bars 25 µm.
Fig. 1 Sall4 is upregulated in hyperplastic melanocytes. a Experimental scheme of isolated melanocytes for RNA sequencing either from Tyr::CreERT2; R26R-LSL-tdTomato wild-type mice or Tyr::CreERT2; R26R-LSL-tdTomato; Tyr::NrasQ61K; Cdkn2a−/− mice with hyperplastic, melanoma-prone skin. At the age of 4 months, the mice were injected on 5 consecutive days with 80 µg g−1 body weight tamoxifen to induce tdTomato expression in melanocytes. The hair growth cycle in wild-type animals was synchronized by dorsal hair plucking. Melanocytes were isolated from mouse back skin of wild-type and melanoma model mice (3–6 mice per sample) and FACS sorted for cKit (staining) and tdTomato (endogenous). b Row z-score heatmap of normalized counts from RNA sequencing as illustrated in a. Visualized are the top 20 most upregulated genes comparing hyperplastic (Tyr::NrasQ61K; Cdkn2a−/−) to wild-type melanocytes. Genes are ordered top to bottom with genes with highest LogFC values on top. Cutoffs were set at p values < 0.05 and FDR < 0.05. Sall4 (LogFC value = 9.59) represents the only and hence highest upregulated transcription factor within those top 20 upregulated genes. The complete list of all differentially expressed genes can be found under Supplementary Data 1. c Immunohistochemical staining of wild-type melanocytes in murine hair follicles (left panel) and melanoma-prone melanocytes in hyperplastic Tyr::NrasQ61K; Cdkn2a−/− mouse skin (right panel). Arrowheads point towards wild-type melanocytes with undetectable Sall4 expression; arrows point towards hyperplastic and rare wild-type melanocytes with detectable Sall4 protein. Experiment has been repeated independently three times with similar results. Scale bars 25 µm.CC BY · PubMed Central
Fig. 2 Sall4 is essential for primary tumor formation, but its depletion leads to increased micrometastasis. a Genetics scheme of the Tyr::NrasQ61K; Cdkn2a−/− transgenic mouse model spontaneously developing melanoma, which was crossed with inducible Tyr:CreERT2; Sall4lox/lox; R26R-LSL-GFP mice, allowing ablation of Sall4 from the melanocytic lineage upon tamoxifen administration. b Experimental scheme depicting how at 1 month of age the experimental mice from a undergo Cre-mediated recombination due to 5 consecutive i.p. tamoxifen injections. Hyperplasia gradually develops from birth of the pups. Primary tumors and metastasis were assessed at around 6 months of age. c Photographs of control and heterozygous (Sall4lox/wt; termed Sall4+/− cko) and homozygous (Sall4lox/lox; termed Sall4−/− cko) Sall4 cko animals (left panel). Hematoxylin and eosin staining of back skin from respective control, Sall4+/− cko or Sall4−/− cko animals (right panel), which has been repeated in independent experiments with similar results 7 times. Scale bars 500 µm. d Quantification of primary tumor numbers of control (Sall4+/+ and non-tamoxifen-injected animals), Sall4+/− cko and Sall4−/− cko animals. e Quantification of proliferation rate, assessed by immunohistochemistry (see Supplementary Fig. 3c), in primary tumors of control and Sall4+/− cko animals. f Binocular images of mouse lungs. The endogenous fluorescent GFP signal was imaged under a fluorescent binocular and for visualization inverted and set to black/white (B/W). Dark spots therefore represent inverted GFP+ spots set to B/W. Scale bars 500 µm. g Immunohistochemical stainings of mouse lung sections to verify melanoma identity of GFP+ spots by means of MITF expression. Scale bars top panel 100 µm, second and third panel 25 µm. h Quantification of GFP+ lung metastases of tamoxifen-injected control (Sall4+/+), Sall4+/− cko, and Sall4−/− cko animals. Metastasis score = 0 indicates <5 GFP+ lesions, 1 >5 lesions, 2 >20 lesions, 3 >50 lesions, 4 >100 lesions. In d, e, h, error bars represent mean ± SEM with N indicated in the respective figures. Two-sided t-tests between groups were performed for significance with p values ≥0.05 = n.s.; <0.05 = *; <0.01 = **, with Sall4−/− cko in d P = 0.0049; Sall4+/− cko in e P = 0.0456; Sall4+/− cko in h P = 0.0011; Sall4−/− cko in h P = 0.0129. Source data for d, e, h are provided as a Source Data file.
Fig. 2 Sall4 is essential for primary tumor formation, but its depletion leads to increased micrometastasis. a Genetics scheme of the Tyr::NrasQ61K; Cdkn2a−/− transgenic mouse model spontaneously developing melanoma, which was crossed with inducible Tyr:CreERT2; Sall4lox/lox; R26R-LSL-GFP mice, allowing ablation of Sall4 from the melanocytic lineage upon tamoxifen administration. b Experimental scheme depicting how at 1 month of age the experimental mice from a undergo Cre-mediated recombination due to 5 consecutive i.p. tamoxifen injections. Hyperplasia gradually develops from birth of the pups. Primary tumors and metastasis were assessed at around 6 months of age. c Photographs of control and heterozygous (Sall4lox/wt; termed Sall4+/− cko) and homozygous (Sall4lox/lox; termed Sall4−/− cko) Sall4 cko animals (left panel). Hematoxylin and eosin staining of back skin from respective control, Sall4+/− cko or Sall4−/− cko animals (right panel), which has been repeated in independent experiments with similar results 7 times. Scale bars 500 µm. d Quantification of primary tumor numbers of control (Sall4+/+ and non-tamoxifen-injected animals), Sall4+/− cko and Sall4−/− cko animals. e Quantification of proliferation rate, assessed by immunohistochemistry (see Supplementary Fig. 3c), in primary tumors of control and Sall4+/− cko animals. f Binocular images of mouse lungs. The endogenous fluorescent GFP signal was imaged under a fluorescent binocular and for visualization inverted and set to black/white (B/W). Dark spots therefore represent inverted GFP+ spots set to B/W. Scale bars 500 µm. g Immunohistochemical stainings of mouse lung sections to verify melanoma identity of GFP+ spots by means of MITF expression. Scale bars top panel 100 µm, second and third panel 25 µm. h Quantification of GFP+ lung metastases of tamoxifen-injected control (Sall4+/+), Sall4+/− cko, and Sall4−/− cko animals. Metastasis score = 0 indicates <5 GFP+ lesions, 1 >5 lesions, 2 >20 lesions, 3 >50 lesions, 4 >100 lesions. In d, e, h, error bars represent mean ± SEM with N indicated in the respective figures. Two-sided t-tests between groups were performed for significance with p values ≥0.05 = n.s.; <0.05 = *; <0.01 = **, with Sall4−/− cko in d P = 0.0049; Sall4+/− cko in e P = 0.0456; Sall4+/− cko in h P = 0.0011; Sall4−/− cko in h P = 0.0129. Source data for d, e, h are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 SALL4 knockdown leads to reduced proliferation and increased invasion. a–c SALL4 expression after 48 h knockdown with two different siRNAs assessed by western blot (top panel and bottom panel left (quantification)) and qRT-PCR (bottom panel right) on the same samples. Experiments performed in human melanoma cells with different mutational backgrounds: M010817 (NRASQ61K), M070302 (unknown mutational status), M150548 (BRAFV600E). siS4: siSALL4. d–f xCELLigence real-time analysis of cell proliferation (Cell Index) of M010817, M070302, and M150548 cells after 48 h siRNA-mediated SALL4 knockdown as in a–c. Three samples per experimental group were analyzed, each consisting of four technical replicas (proliferation wells analyzed by xCELLigence). g–h In vivo xenografts after SALL4 knockdown: 24 h after siRNA treatment in vitro, cells were grafted subcutaneously onto nude mice and let grown for 6 days, when images were taken and tumor sizes of M010817 and M150548-derived grafts were quantified. Scale units = 1 mm. i–k Corning Transwell® invasion assay: siControl or siSALL4-treated cells (48 h) were seeded onto the porous, matrigel-covered membrane of an invasion chamber insert and let to migrate from FCS-free (top chamber) to FCS high (lower chamber) medium. Numbers of invaded cells on the bottom side of the invasion membrane were analyzed after 24 h. Invaded cells were stained with DAPI, imaged and set to black and white (top panels) for quantification (bottom panels). Scale bars 200 µm. Error bars represent mean ± SD and for significance, two-sided t-tests were performed with N = 3 (a–f) and N = 4 (g–k) and p values ≥0.05 = n.s.; <0.05 = *; <0.01 = ** and <0.001 = *** with siRNA#1 in a (lower left panel) P = 0.0001; siRNA#2 in a (lower left panel) P = 0.0015; siRNA#1 in a (lower right panel) P = 0.0099; siRNA#2 in a (lower right panel) P = 0.0476; siRNA#1 in b (lower left panel) P = 0.0070; siRNA#2 in b (lower left panel) P = 0.0133; siRNA#1 in b (lower right panel) P = 0.0006; siRNA#2 in b (lower right panel) P = 0.0058; siRNA#2 in c (lower left panel) P = 0.0094; siRNA#1 in c (lower right panel) P = 0.0016; siRNA#2 in c (lower right panel) P = 0.0129; siRNA#1 in g P = 0.0372; siRNA#2 in g P = 0.0047; siRNA#1 in h P = 0.0117; P in i = 0.0009; P in j = 0.0012; P in k = 0.0129. Source data for all panels are provided as a Source Data file.
Fig. 3 SALL4 knockdown leads to reduced proliferation and increased invasion. a–c SALL4 expression after 48 h knockdown with two different siRNAs assessed by western blot (top panel and bottom panel left (quantification)) and qRT-PCR (bottom panel right) on the same samples. Experiments performed in human melanoma cells with different mutational backgrounds: M010817 (NRASQ61K), M070302 (unknown mutational status), M150548 (BRAFV600E). siS4: siSALL4. d–f xCELLigence real-time analysis of cell proliferation (Cell Index) of M010817, M070302, and M150548 cells after 48 h siRNA-mediated SALL4 knockdown as in a–c. Three samples per experimental group were analyzed, each consisting of four technical replicas (proliferation wells analyzed by xCELLigence). g–h In vivo xenografts after SALL4 knockdown: 24 h after siRNA treatment in vitro, cells were grafted subcutaneously onto nude mice and let grown for 6 days, when images were taken and tumor sizes of M010817 and M150548-derived grafts were quantified. Scale units = 1 mm. i–k Corning Transwell® invasion assay: siControl or siSALL4-treated cells (48 h) were seeded onto the porous, matrigel-covered membrane of an invasion chamber insert and let to migrate from FCS-free (top chamber) to FCS high (lower chamber) medium. Numbers of invaded cells on the bottom side of the invasion membrane were analyzed after 24 h. Invaded cells were stained with DAPI, imaged and set to black and white (top panels) for quantification (bottom panels). Scale bars 200 µm. Error bars represent mean ± SD and for significance, two-sided t-tests were performed with N = 3 (a–f) and N = 4 (g–k) and p values ≥0.05 = n.s.; <0.05 = *; <0.01 = ** and <0.001 = *** with siRNA#1 in a (lower left panel) P = 0.0001; siRNA#2 in a (lower left panel) P = 0.0015; siRNA#1 in a (lower right panel) P = 0.0099; siRNA#2 in a (lower right panel) P = 0.0476; siRNA#1 in b (lower left panel) P = 0.0070; siRNA#2 in b (lower left panel) P = 0.0133; siRNA#1 in b (lower right panel) P = 0.0006; siRNA#2 in b (lower right panel) P = 0.0058; siRNA#2 in c (lower left panel) P = 0.0094; siRNA#1 in c (lower right panel) P = 0.0016; siRNA#2 in c (lower right panel) P = 0.0129; siRNA#1 in g P = 0.0372; siRNA#2 in g P = 0.0047; siRNA#1 in h P = 0.0117; P in i = 0.0009; P in j = 0.0012; P in k = 0.0129. Source data for all panels are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 RNA sequencing of SALL4 knockdown reveals an invasiveness gene expression signature. a RNA seq row z-score heatmap of differentially expressed (DE) genes after 48 h SALL4 knockdown in the human cell line M010817. Cutoffs were set at Log2 ratio ≥ 0.27 or ≤−0.27, p value < 0.05 and FDR < 0.05 and resulted in 1004 genes significantly upregulated and 1140 genes significantly downregulated. b Top 12 MetaCoreTM process networks of upregulated genes. Top ten most upregulated genes per process are listed and genes validated in additional cell lines are highlighted in bold. c Top 12 MetaCoreTM process networks of downregulated genes. Top ten most downregulated genes per process are listed and genes validated in additional cell lines are highlighted in bold. d Gene Set Enrichment Analysis (GSEA) of DE genes after SALL4 knockdown (log2 ratio-ranked) as in a with published genesets characterizing invasive versus proliferative melanoma cells40–42. e Log2 expression ratio heatmap of qRT-PCR-based gene expression analysis of specific genes of interest (normalized to PPIA and set relative to siCtrl-treated cells) in human melanoma cell lines (M010817: NRASQ61K; M070302: unknown mutational status; M150548: BRAFV600E; M121224: NRASQ61K and BRAFV600E; MM150536: BRAFV600E) after 48 h treatment with two different siRNAs targeting SALL4. Two-sided t-tests were performed with N = 3 and p values ≥ 0.05 = n.s. Source data for e are provided as a Source Data file.
Fig. 4 RNA sequencing of SALL4 knockdown reveals an invasiveness gene expression signature. a RNA seq row z-score heatmap of differentially expressed (DE) genes after 48 h SALL4 knockdown in the human cell line M010817. Cutoffs were set at Log2 ratio ≥ 0.27 or ≤−0.27, p value < 0.05 and FDR < 0.05 and resulted in 1004 genes significantly upregulated and 1140 genes significantly downregulated. b Top 12 MetaCoreTM process networks of upregulated genes. Top ten most upregulated genes per process are listed and genes validated in additional cell lines are highlighted in bold. c Top 12 MetaCoreTM process networks of downregulated genes. Top ten most downregulated genes per process are listed and genes validated in additional cell lines are highlighted in bold. d Gene Set Enrichment Analysis (GSEA) of DE genes after SALL4 knockdown (log2 ratio-ranked) as in a with published genesets characterizing invasive versus proliferative melanoma cells40–42. e Log2 expression ratio heatmap of qRT-PCR-based gene expression analysis of specific genes of interest (normalized to PPIA and set relative to siCtrl-treated cells) in human melanoma cell lines (M010817: NRASQ61K; M070302: unknown mutational status; M150548: BRAFV600E; M121224: NRASQ61K and BRAFV600E; MM150536: BRAFV600E) after 48 h treatment with two different siRNAs targeting SALL4. Two-sided t-tests were performed with N = 3 and p values ≥ 0.05 = n.s. Source data for e are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 SALL4 and HDAC2 interact and have a set of common target genes in melanoma cells. a Western blot for SALL4 and HDAC2 after Co-Immunoprecipitation (Co-IP) with a SALL4 antibody in the human melanoma cells M010817. Experiment has been repeated independently with similar results two times. b CUT&RUN (C&R) in M010817 cells with two antibodies against SALL4 (SALL4_Ab#1 (S_Ab#1) and SALL4_Ab#2 (S_Ab#2)) and two antibodies against HDAC2 (HDAC2_Ab#1 (H_Ab#1) and HDAC2_Ab#2 (H_Ab#2)) and Ctrl (anti-FLAG) visualized as read density heatmaps of the centered peaks (within 10 kb) for all loci showing peaks with at least 3 of the 4 (2x SALL4, 2x HDAC2) antibodies. c C&R peak numbers called with SEACR for single antibodies, shared between antibodies and shared between at least 3 of the 4 SALL4-HDAC2 antibodies. In total 3319 loci contained peaks for at least 3 of 4 antibodies tested and were found in total 2301 different genes. Those peaks were used for further analyses correlating the direct targets with either expression (Fig. 6a, b) or acetylation status (Fig. 7h). d Annotation of C&R peaks to genetic regions. Green: the 5019 SALL4_Ab#1 and SALL4_Ab#2 shared peaks; yellow: the 1925 HDAC2_Ab#1 and HDAC2_Ab#2 shared peaks; grey: the 3319 peaks shared between at least 3 of the 4 SALL4_Ab#1, SALL4_Ab#2, HDAC2_Ab#1, and HDAC2_Ab#2 antibodies. TTS: transcription termination site, TSS: transcription start site, UTR: untranslated region. e–i Specific gene tracks visualized with IGV. Green: SALL4_Ab#1 and SALL4_Ab#2; yellow; HDAC2_Ab#1, and HDAC2_Ab#2. Red dashed lines highlight significantly called peaks (with at least 3 of 4 antibodies). j Selected de novo DNA binding motifs of SALL4-HDAC2 (at least 3 of 4 antibodies) shared peaks analyzed by HOMER. Source data for a and d are provided as a Source Data file.
Fig. 5 SALL4 and HDAC2 interact and have a set of common target genes in melanoma cells. a Western blot for SALL4 and HDAC2 after Co-Immunoprecipitation (Co-IP) with a SALL4 antibody in the human melanoma cells M010817. Experiment has been repeated independently with similar results two times. b CUT&RUN (C&R) in M010817 cells with two antibodies against SALL4 (SALL4_Ab#1 (S_Ab#1) and SALL4_Ab#2 (S_Ab#2)) and two antibodies against HDAC2 (HDAC2_Ab#1 (H_Ab#1) and HDAC2_Ab#2 (H_Ab#2)) and Ctrl (anti-FLAG) visualized as read density heatmaps of the centered peaks (within 10 kb) for all loci showing peaks with at least 3 of the 4 (2x SALL4, 2x HDAC2) antibodies. c C&R peak numbers called with SEACR for single antibodies, shared between antibodies and shared between at least 3 of the 4 SALL4-HDAC2 antibodies. In total 3319 loci contained peaks for at least 3 of 4 antibodies tested and were found in total 2301 different genes. Those peaks were used for further analyses correlating the direct targets with either expression (Fig. 6a, b) or acetylation status (Fig. 7h). d Annotation of C&R peaks to genetic regions. Green: the 5019 SALL4_Ab#1 and SALL4_Ab#2 shared peaks; yellow: the 1925 HDAC2_Ab#1 and HDAC2_Ab#2 shared peaks; grey: the 3319 peaks shared between at least 3 of the 4 SALL4_Ab#1, SALL4_Ab#2, HDAC2_Ab#1, and HDAC2_Ab#2 antibodies. TTS: transcription termination site, TSS: transcription start site, UTR: untranslated region. e–i Specific gene tracks visualized with IGV. Green: SALL4_Ab#1 and SALL4_Ab#2; yellow; HDAC2_Ab#1, and HDAC2_Ab#2. Red dashed lines highlight significantly called peaks (with at least 3 of 4 antibodies). j Selected de novo DNA binding motifs of SALL4-HDAC2 (at least 3 of 4 antibodies) shared peaks analyzed by HOMER. Source data for a and d are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 SALL4-HDAC2 targets that are upregulated after SALL4 depletion or HDAC inhibition enrich in invasion-related processes. a Significantly upregulated genes after SALL4 knockdown (Fig. 4a, b) were overlaid with the C&R data of direct SALL4-HDAC2 targets (Fig. 5b, c), which resulted in 184 direct SALL4-HDAC2 targets significantly upregulated after SALL4 knockdown. b MetaCore™ Process Network enrichment of the 184 direct targets from a. The top 12 most significant processes are given with the specific genes of each process listed in red. Genes that were validated for DE in other cell lines are highlighted in bold. c Log2 fold change heatmap of qRT-PCR-based gene expression (normalized to PPIA and set relative to vehicle (DMSO)-treated samples) after 48 h cell treatment with the HDAC inhibitors Mocetinostat (0.6 µM) and Panobinostat (7 nM). t-tests were performed for significance between HDACi and vehicle-treated groups with N = 3 and p values ≥ 0.05 = not significant (n.s.). d Images of DAPI-stained nuclei in invasion assays as in Fig. 3 i–k. Cells were seeded into the invasion chamber, which was supplemented with vehicle or 600 nM Mocetinostat or 7 nM Panobinostat in both the starvation as well as the FCS high medium. After 24 h, the invaded cells were analyzed by counting DAPI-stained nuclei of invaded cells at the bottom of the membrane (inverted and set to black and white (B/W)). Scale bars 200 µm. e Quantification of invaded cells in d set relative to control cells. Moce: mocetinostat, Pano: panobinostat. Error bars represent mean ± SD in e. For significance, two-sided t-tests were performed with N = 3 (c) and N = 4 (e) and p values ≥0.05 = n.s.; <0.05 = *; <0.01 = **; and <0.001 = *** with Moce in e (top panel) P = 0.0218; Moce in e (middle panel) P = 0.0051; Pano in e (middle panel) P = 0.0463; Moce in e (lower panel) P = 0.0332; Pano in e (lower panel) P = 0.0051. Source data for c and e are provided as a Source Data file.
Fig. 6 SALL4-HDAC2 targets that are upregulated after SALL4 depletion or HDAC inhibition enrich in invasion-related processes. a Significantly upregulated genes after SALL4 knockdown (Fig. 4a, b) were overlaid with the C&R data of direct SALL4-HDAC2 targets (Fig. 5b, c), which resulted in 184 direct SALL4-HDAC2 targets significantly upregulated after SALL4 knockdown. b MetaCore™ Process Network enrichment of the 184 direct targets from a. The top 12 most significant processes are given with the specific genes of each process listed in red. Genes that were validated for DE in other cell lines are highlighted in bold. c Log2 fold change heatmap of qRT-PCR-based gene expression (normalized to PPIA and set relative to vehicle (DMSO)-treated samples) after 48 h cell treatment with the HDAC inhibitors Mocetinostat (0.6 µM) and Panobinostat (7 nM). t-tests were performed for significance between HDACi and vehicle-treated groups with N = 3 and p values ≥ 0.05 = not significant (n.s.). d Images of DAPI-stained nuclei in invasion assays as in Fig. 3 i–k. Cells were seeded into the invasion chamber, which was supplemented with vehicle or 600 nM Mocetinostat or 7 nM Panobinostat in both the starvation as well as the FCS high medium. After 24 h, the invaded cells were analyzed by counting DAPI-stained nuclei of invaded cells at the bottom of the membrane (inverted and set to black and white (B/W)). Scale bars 200 µm. e Quantification of invaded cells in d set relative to control cells. Moce: mocetinostat, Pano: panobinostat. Error bars represent mean ± SD in e. For significance, two-sided t-tests were performed with N = 3 (c) and N = 4 (e) and p values ≥0.05 = n.s.; <0.05 = *; <0.01 = **; and <0.001 = *** with Moce in e (top panel) P = 0.0218; Moce in e (middle panel) P = 0.0051; Pano in e (middle panel) P = 0.0463; Moce in e (lower panel) P = 0.0332; Pano in e (lower panel) P = 0.0051. Source data for c and e are provided as a Source Data file.CC BY · PubMed Central
Fig. 7 SALL4 can regulate invasiveness genes through an epigenetic mechanism. a Read density heatmap of gained and lost H3K27ac ChIP sequencing peaks (±2 kb) upon SALL4 knockdown (left panels) and average read distribution of gained and lost H3K27ac peaks within ±5 kb from peak center (right panels). b Distribution of the gained and lost H3K27ac peaks in different genetic regions. TTS: transcription termination site, TSS: transcription start site, UTR: untranslated region. c–g Representative tracks of invasiveness genes with significantly gained (red bars; highlighted by red, dashed lines) H3K27ac peaks in siSALL4 over siCtrl (no significantly lost H3K27ac peaks were detected for the visualized gene tracks). h Read density heatmap of differential H3K27ac ChIP-seq peaks (within 10 kb) in siSALL4 over siCtrl at direct target genes of SALL4-HDAC2 (CUT&RUN peaks with at least 3 of 4 SALL4/HDAC2 antibodies). i Significantly upregulated genes after SALL4 knockdown (Fig. 4a, b) were overlaid with those genes that have significantly gained H3K27ac marks −15/+10 kb of TSS (a, ocher panel). This resulted in 261 genes with activating chromatin marks that were at the same time upregulated after SALL4 knockdown. j MetaCore™ Process Network enrichment of the 261 genes from i. The top 12 most significant processes are indicated with the specific genes of each process listed in red. k Gene Set Enrichment Analysis (GSEA) of the combined 261 upregulated (i) and 137 downregulated genes (Supplementary Fig. 17a) with differential acetylation after SALL4 knockdown (ranked according to log2 expression ratio of RNA seq results) with the previously published melanoma programs of Verfaillie and colleagues (2015). Source data for b are provided as a Source Data file.
Fig. 7 SALL4 can regulate invasiveness genes through an epigenetic mechanism. a Read density heatmap of gained and lost H3K27ac ChIP sequencing peaks (±2 kb) upon SALL4 knockdown (left panels) and average read distribution of gained and lost H3K27ac peaks within ±5 kb from peak center (right panels). b Distribution of the gained and lost H3K27ac peaks in different genetic regions. TTS: transcription termination site, TSS: transcription start site, UTR: untranslated region. c–g Representative tracks of invasiveness genes with significantly gained (red bars; highlighted by red, dashed lines) H3K27ac peaks in siSALL4 over siCtrl (no significantly lost H3K27ac peaks were detected for the visualized gene tracks). h Read density heatmap of differential H3K27ac ChIP-seq peaks (within 10 kb) in siSALL4 over siCtrl at direct target genes of SALL4-HDAC2 (CUT&RUN peaks with at least 3 of 4 SALL4/HDAC2 antibodies). i Significantly upregulated genes after SALL4 knockdown (Fig. 4a, b) were overlaid with those genes that have significantly gained H3K27ac marks −15/+10 kb of TSS (a, ocher panel). This resulted in 261 genes with activating chromatin marks that were at the same time upregulated after SALL4 knockdown. j MetaCore™ Process Network enrichment of the 261 genes from i. The top 12 most significant processes are indicated with the specific genes of each process listed in red. k Gene Set Enrichment Analysis (GSEA) of the combined 261 upregulated (i) and 137 downregulated genes (Supplementary Fig. 17a) with differential acetylation after SALL4 knockdown (ranked according to log2 expression ratio of RNA seq results) with the previously published melanoma programs of Verfaillie and colleagues (2015). Source data for b are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

20 Valid · 3 Not valid · 5 Not checked · 89 Own results and interpretations

60 more claims · 4 with their cited sources checked

Create a free account to see all 117 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 32
  • Probably not a substantial claim. 26
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 92 references

Cited by

See all 34

Metadata

Authors
Diener, J., Baggiolini, A., Pernebrink, M., Dalcher, D., Lerra, L., Cheng, P. F., Varum, S., Häusel, J., Stierli, S., Treier, M., Studer, L., Basler, K., Levesque, M. P., Dummer, R., Santoro, R., Cantù, C., & Sommer, L.
Affiliations
  • University of Zurich (CH)
  • Memorial Sloan Kettering Cancer Center (US)
  • Linköping University (SE)
  • University Hospital Zurich (CH)
  • Max Delbrück Center (DE)
Corresponding author
Sommer, Lukas
Venue
Nature Communications
Published
2021-08-20
Volume
12
Issue
1
Pages
5056-5056
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3193314715
Cited by
34
References
95
Citations by year
2026: 4 · 2025: 8 · 2024: 6 · 2023: 5 · 2022: 9 · 2021: 2
FWCI
1.73
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
  • DiVA (Linkoping University) (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (169859, 192075, 310030)
  • Cancerfonden (CAN 2018/542)
  • Knut och Alice Wallenbergs Stiftelse
  • Universität Zürich
  • Swiss Cancer Research Foundation
  • Functional Genomics Center Zurich
  • National Cancer Institute (P30CA008748)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
SALL4, melanoma, tumor invasion, HDAC2, histone acetylation, epigenetic regulation, micrometastases, phenotypic switching, NRAS Q61K, histone deacetylase inhibition
MeSH terms
Acetylation, Animals, Base Sequence, Cell Adhesion, DNA-Binding Proteins, Histones, Humans, Melanocytes, Melanoma, Mice, Nude, Mice, Transgenic, Neoplasm Invasiveness, Protein Binding, Skin Neoplasms, Transcription Factors, Gene Expression Regulation, Neoplastic, Cell Lineage, Stem Cell Factor, Gene Expression Profiling, Epigenesis, Genetic, Cell Line, Tumor, Tumor Burden, Cell Proliferation, Mice, Histone Deacetylase 2, Neoplasm Micrometastasis, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4. https://app.cochat.ai/papers/10.1038/s41467-021-25326-8
The paper
Diener, J., Baggiolini, A., Pernebrink, M., Dalcher, D., Lerra, L., Cheng, P. F., Varum, S., Häusel, J., Stierli, S., Treier, M., Studer, L., Basler, K., Levesque, M. P., Dummer, R., Santoro, R., Cantù, C., & Sommer, L. (2021). Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4. Nature Communications. https://doi.org/10.1038/s41467-021-25326-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.